All Stories
Follow
Subscribe to STRATEC Biomedical AG

STRATEC Biomedical AG

ots Ad hoc-Service: STRATEC Biomedical Sys. <DE0007289001> STRATEC Biomedical Systems AG Concludes Development and Supply Agreement with the Akzo Nobel Subsidiary Organon Teknika

Birkenfeld (ots Ad hoc-Service) -

The sender is solely responsible for the contents of this
announcement.
STRATEC Biomedical Systems AG Birkenfeld (WKN 728900) is one of
the leading suppliers of automated systems for bioanalytical and
diagnostics applications.
STRATEC Biomedical Systems AG has signed a development and supply
agreement with Organon Teknika B.V., the Netherlands. Subject matter
of this agreement is the development and thereafter subsequent
delivery of fully automated high throughput systems based on
STRATEC's PlateRunner system platform for a period of several years.
Organon Teknika, one of the leading companies in the field of
infectious disease diagnostics in blood banks expects to further
strenghten its position in the market with this fully automated
analyzer.
Regarding the time of product launch and the business volume, we
have agreed with Organon Teknika to maintain confidentiality for
competitive reasons. Based on this agreement, STRATEC Biomedical
Systems AG expects an not insignificant expansion of its turnover in
the coming years.
Organon Teknika will market the systems under its own brand name
together with its reagents.
The conclusion of this major, long-term contract highlights the
potential of the PlateRunner system platform and the performance of
the STRATEC Biomedical Systems AG in the diagnostics and life
sciences market.
STRATEC Biomedical Systems AG 
   Board of Management
For further information, please contact: www.stratec-biomedical.de
ir@stratec-biomedical.de
or +49 (0) 7082 - 79 16 27
End of Message
Internet: http://recherche.newsaktuell.de

Original content of: STRATEC Biomedical AG, transmitted by news aktuell

More stories: STRATEC Biomedical AG
More stories: STRATEC Biomedical AG